Live

pipeline advancement

2 articles

Amgen Raises Q2 2026 Dividend to $2.52 Per Share, Signals Confidence

Benzinga

Benzinga·Mar 4·Prnewswire

Amgen Raises Q2 2026 Dividend to $2.52 Per Share, Signals Confidence

Amgen declared $2.52 per share dividend for Q2 2026, payable June 5, while advancing pipeline in cancer, cardiovascular, and obesity treatments.

AMGNshareholder returnsdividend announcement

Lantheus Shifts Strategy, Posts $1.54B in 2025 Revenue Amid Pipeline Expansion

GlobeNewswire Inc.

GlobeNewswire Inc.·Feb 26·Na

Lantheus Shifts Strategy, Posts $1.54B in 2025 Revenue Amid Pipeline Expansion

Lantheus posted $1.54B in 2025 revenue but faces Q4 headwinds. The company plans to refocus on PET diagnostics while exploring options for radiotherapy assets, expecting four FDA approvals in 2026.

LNTHearningsacquisitions